| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |